Table 5—

Summary of adverse events(related and unrelated to study drug)

Adverse eventsSubjects n (%)#
Respiratory tract infection5 (41.7)
Cough2 (16.7)
Lower-limb oedema2 (16.7)
Arthralgia1 (8.3)
Bronchospasm1 (8.3)
Fungal infection1 (8.3)
Hepatic function abnormal1 (8.3)
Hypotension1 (8.3)
Multiorgan failure1 (8.3)
Pneumonia cytomegaloviral1 (8.3)
Pneumonia1 (8.3)
Respiratory failure1 (8.3)
Sepsis1 (8.3)
V′/Q′ scan abnormal1 (8.3)
Positional vertigo1 (8.3)
  • V′/Q′: ventilation/perfusion. #: Of a total of 12 patients.